Health

The use of monoclonal antibody nirsevimab (Beyfortus) in protecting young infants from hospitalization due to respiratory syncytial virus (RSV) has been a topic of discussion in the medical community. The French prospective ENVIE study conducted by Naim Ouldali, MD, PhD, and colleagues has shed light on the effectiveness of nirsevimab in preventing RSV-related hospital admissions,
0 Comments
The recent American Society of Clinical Oncology (ASCO) meeting unveiled a promising study regarding the use of liposomal gemcitabine in combination with pembrolizumab for the treatment of advanced solid tumors. Charles Farber, MD, PhD, of Atlantic Hematology Oncology in Morristown, New Jersey, shared insights on the feasibility and tolerability of this innovative combination therapy. Gemcitabine,
0 Comments
House Republicans have initiated an investigation into President Biden’s physician, Dr. Kevin O’Connor, following concerns raised about Biden’s debate performance. They have requested a closed-door interview with Dr. O’Connor to gather more information. Expert in Parkinson’s Disease Visits White House An expert in Parkinson’s disease has visited the White House on multiple occasions since August
0 Comments
Dr. Sara Karaba from Johns Hopkins University School of Medicine claims that using extended infusion antibiotics for bloodstream infections has “the most bang for its buck.” This statement suggests that this strategy is highly cost-effective and efficient in treating such infections. However, it is essential to consider the potential risks and side effects of prolonged
0 Comments
The recent case involving a Seattle-area plastic surgery provider, Allure Esthetic, and its owner Javad Sajan, MD, has shed light on the unethical practices that exist in the plastic surgery industry. Accusations of threatening patients over negative reviews, posting fake positive reviews, and enforcing illegal nondisclosure agreements have led to a federal consent decree requiring
0 Comments
A recent study conducted by Elyse Kharbanda, MD, MPH, and colleagues at the HealthPartners Institute in Bloomington, Minnesota, has found that receiving an mRNA COVID-19 vaccine during the first trimester of pregnancy does not increase the risk of major structural birth defects. This retrospective cohort study analyzed data from multiple Vaccine Safety Datalink sites and
0 Comments